•  63
    Moral Judges and Human Ideals
    Philosophy and Phenomenological Research 55 (4): 957-962. 1995.
    Developing a vision of morality that is at once compelling and comprehensive is an enormous task. The questions and answers all interlock, making it difficult to know where to start. Most of us, I think, just jump in, with whatever issue or controversy grabs us. We make what headway we can with the section of the moral puzzle on which we choose to work and hope or trust that when we or others work on other sections, the results will fit smoothly, consistently, even supportively with our current …Read more
  •  290
    Multiculturalism: Expanded Paperback Edition
    with Kwame Anthony Appiah, Charles Taylor, Jürgen Habermas, Stephen C. Rockefeller, and Michael Walzer
    Princeton University Press. 1994.
    A new edition of the highly acclaimed book Multiculturalism and "The Politics of Recognition," this paperback brings together an even wider range of leading philosophers and social scientists to probe the political controversy surrounding ...
  •  6
    Inviting clinicians to Kill…
    Hastings Center Report 20 (2): 51-51. 2012.
  •  6
    Above and Below the Line of Duty
    Philosophical Topics 14 (2): 131-148. 1986.
  •  9
    The Challenge of Developing Oversight Approaches to Nanobiotechnology
    with Jordan Paradise, Jennifer Kuzma, Gurumurthy Ramachandran, and Efrosini Kokkoli
    Journal of Law, Medicine and Ethics 37 (4): 543-545. 2009.
  •  18
    Introduction
    with Jordan Paradise, Jennifer Kuzma, Gurumurthy Ramachandran, and Efrosini Kokkoli
    Journal of Law, Medicine and Ethics 37 (4): 543-545. 2009.
  •  35
    Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences
    with Jordan Paradise, Jennifer Kuzma, Aliya Kuzhabekova, Alison W. Tisdale, Efrosini Kokkoli, and Gurumurthy Ramachandran
    Journal of Law, Medicine and Ethics 37 (4): 688-705. 2009.
    The emergence of nanotechnology, and specifically nanobiotechnology, raises major oversight challenges. In the United States, government, industry, and researchers are debating what oversight approaches are most appropriate. Among the federal agencies already embroiled in discussion of oversight approaches are the Food and Drug Administration , Environmental Protection Agency , Department of Agriculture , Occupational Safety and Health Administration , and National Institutes of Health . All can…Read more
  •  22
    Multiculturalism and "The Politics of Recognition"
    with Alison M. Jaggar, Charles Taylor, Amy Gutmann, Steven C. Rockefeller, and Michael Walzer
    Hastings Center Report 24 (5): 44. 1994.
    Multiculturalism and “The Politics of Recognition.” An Essay by Charles Taylor with commentary by Amy Gutmann, editor, Steven C. Rockefeller, Michael Walzer, and Susan Wolf.
  •  3
    Introduction: The Public Duties of the Professions
    with Bruce Jennings and Daniel Callahan
    Hastings Center Report 17 (1): 1-2. 1987.
  •  24
    The Professions: Public Interest and Common Good
    with Bruce Jennings and Daniel Callahan
    Hastings Center Report 17 (1): 3-10. 1987.
  •  84
    Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field
    with Leili Fatehi, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nancy M. P. King, Efrosini Kokkoli, Gary Marchant, Andrew D. Maynard, Martin Philbert, Gurumurthy Ramachandran, Ronald A. Siegel, and Samuel Wickline
    Journal of Law, Medicine and Ethics 40 (4): 716-750. 2012.
    Nanomedicine is yielding new and improved treatments and diagnostics for a range of diseases and disorders. Nanomedicine applications incorporate materials and components with nanoscale dimensions where novel physiochemical properties emerge as a result of size-dependent phenomena and high surface-to-mass ratio. Nanotherapeutics and in vivo nanodiagnostics are a subset of nanomedicine products that enter the human body. These include drugs, biological products, implantable medical devices, and c…Read more
  •  503
    Freedom Within Reason
    Oup Usa. 1990.
    In Freedom Within Reason, Susan Wolf charts a course between incompatibilism, or the notion that freedom and responsibility require causal and metaphysical independence from the impersonal forces of nature, and compatibilism, or the notion that people are free and responsible as long as their actions are governed by their desires. Wolf argues that some of the forces which are beyond our control are friends to freedom rather than enemies of it, enabling us to see the world for what it is. The fre…Read more
  •  18
    The Ethical Primate: Humans, Freedom and Morality
    Philosophical Review 106 (1): 131. 1997.
    This short, readable book, aimed at a popular audience, is concerned to show that a naturalistic view of humankind can be reconciled with a commitment to morality and a belief in human freedom.
  •  50
    Realism and Imagination in Ethics
    Philosophical Review 94 (2): 290. 1985.
  •  12
  •  370
    Morality and partiality
    Philosophical Perspectives 6 243-259. 1992.
  •  11
  •  7
    Doing Ethics in Italy
    with Strachan Donnelley
    Hastings Center Report 18 (4): 13-14. 1988.
  •  80
    Above and Below the Line of Duty
    Philosophical Topics 14 (2): 131-148. 1986.
  •  29
    Toward An Expanded Vision of Clinical Ethics Education: From the Individual to the Institution
    with Mildred Z. Solomon, Bruce Jennings, Vivian Guilfoy, Rebecca Jackson, Lydia O'Donnell, Kathleen Nolan, Dieter Koch-Weser, and Strachan Donnelley
    Kennedy Institute of Ethics Journal 1 (3): 225-245. 1991.
    This paper advances a new paradigm in clinical ethics education that not only emphasizes development of individual cli but also focuses on the institutional context within which health care professionals work. This approach has been applied to the goal of improving the care provided to critically and terminally ill adults. The model has been adopted by about thirty hospitals and nursing homes; additional institutions will soon join the program, entitled Decisions Near the End of Life. Here, we d…Read more
  •  36
    Addressing the Ethical Challenges in Genetic Testing and Sequencing of Children
    with Ellen Wright Clayton, Laurence B. McCullough, Leslie G. Biesecker, Steven Joffe, Lainie Friedman Ross, and For the Clinical Sequencing Exploratory Research Group
    American Journal of Bioethics 14 (3): 3-9. 2014.
    American Academy of Pediatrics (AAP) and American College of Medical Genetics (ACMG) recently provided two recommendations about predictive genetic testing of children. The Clinical Sequencing Exploratory Research Consortium's Pediatrics Working Group compared these recommendations, focusing on operational and ethical issues specific to decision making for children. Content analysis of the statements addresses two issues: (1) how these recommendations characterize and analyze locus of decision m…Read more
  • At the Center
    Hastings Center Report 22 (4). 1992.
  •  12
    We agree with Alfandre and colleagues that ethics guidance for contingency conditions in public health emergencies is urgently needed. The Minnesota COVID Ethics Collabora...
  •  41
    What Has Covid‐19 Exposed in Bioethics? Four Myths
    Hastings Center Report 51 (3): 3-4. 2021.
    The Covid‐19 pandemic has exposed four myths in bioethics. First, the flood of bioethics publications on how to allocate scarce resources in crisis conditions has assumed authorities would declare the onset of crisis standards of care, yet few have done so. This leaves guidelines in limbo and patients unprotected. Second, the pandemic's realities have exploded traditional boundaries between clinical, research, and public health ethics, requiring bioethics to face the interdigitation of learning,…Read more
  •  15
    Volume 20, Issue 8, August 2020, Page 41-43.
  •  67
    Ethical Challenges Arising in the COVID-19 Pandemic: An Overview from the Association of Bioethics Program Directors (ABPD) Task Force
    with Amy L. McGuire, Mark P. Aulisio, F. Daniel Davis, Cheryl Erwin, Thomas D. Harter, Reshma Jagsi, Robert Klitzman, Robert Macauley, Eric Racine, Matthew Wynia, and Paul Root Wolpe
    American Journal of Bioethics 20 (7): 15-27. 2020.
    The COVID-19 pandemic has raised a host of ethical challenges, but key among these has been the possibility that health care systems might need to ration scarce critical care resources. Rationing p...
  •  8
    Introduction: The Crucial Role of Law in Supporting Successful Translation of Genomics into Clinical Care
    with Ellen Wright Clayton and Frances Lawrenz
    Journal of Law, Medicine and Ethics 48 (1): 7-10. 2020.
  •  14
    Key Expert Stakeholder Perceptions of the Law of Genomics: Identified Problems and Potential Solutions
    with Fook Yee Cheung, Lauren Clatch, Ellen Wright Clayton, and Frances Lawrenz
    Journal of Law, Medicine and Ethics 48 (1): 87-104. 2020.
    The law applicable to genomics in the United States is currently in transition and under debate. The rapid evolution of the science, burgeoning clinical research, and growing clinical application pose serious challenges for federal and state law. Although there has been some empirical work in this area, this is the first paper to survey and interview key scientific and legal stakeholders in the field of genomics to help ground identification of the most important legal problems that must be solv…Read more
  •  12
    Integrating Rules for Genomic Research, Clinical Care, Public Health Screening and DTC Testing: Creating Translational Law for Translational Genomics
    with Pilar N. Ossorio, Susan A. Berry, Henry T. Greely, Amy L. McGuire, Michelle A. Penny, and Sharon F. Terry
    Journal of Law, Medicine and Ethics 48 (1): 69-86. 2020.
    Human genomics is a translational field spanning research, clinical care, public health, and direct-to-consumer testing. However, law differs across these domains on issues including liability, consent, promoting quality of analysis and interpretation, and safeguarding privacy. Genomic activities crossing domains can thus encounter confusion and conflicts among these approaches. This paper suggests how to resolve these conflicts while protecting the rights and interests of individuals sequenced.…Read more
  •  11
    From Genetics to Genomics: Facing the Liability Implications in Clinical Care
    with Gary Marchant, Mark Barnes, James P. Evans, and Bonnie LeRoy
    Journal of Law, Medicine and Ethics 48 (1): 11-43. 2020.
    Health care is transitioning from genetics to genomics, in which single-gene testing for diagnosis is being replaced by multi-gene panels, genome-wide sequencing, and other multi-genic tests for disease diagnosis, prediction, prognosis, and treatment. This health care transition is spurring a new set of increased or novel liability risks for health care providers and test laboratories. This article describes this transition in both medical care and liability, and addresses 11 areas of potential …Read more